Exact Mass: 500.2985
Exact Mass Matches: 500.2985
Found 66 metabolites which its exact mass value is equals to given mass value 500.2985,
within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error
8.0E-6 dalton.
Mupirocin
Mupirocin (pseudomonic acid A, or Bactroban or Centany) is an antibiotic originally isolated from Pseudomonas fluorescens. It is used topically, and is primarily effective against Gram-positive bacteria. Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. Mupirocin has a unique mechanism of action, which is selective binding to bacterial isoleucyl-tRNA synthetase, which halts the incorporation of isoleucine into bacterial proteins. Because this mechanism of action is not shared with any other antibiotic, mupirocin has few problems of antibiotic cross-resistance. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Same as: D01076 Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].
9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid
3,15-Dihydroxy-ent-labd-7-en-oic acid 3-O-beta-D-glucoside
ent-8R,13S;15,17-diepoxy-3beta-D-glucopyranosyloxylabdan-14alpha-ol|microtropioside A
16-O-beta-D-Glucopyranoside-(ent-3beta, 13xi)-7-Pimarene-3, 15, 16, 18-tetrol
ent-2beta,15,16,19-tetrahydroxypimar-8(14)-en-19-O-beta-glucopyranoside
(1beta,5beta,8xi,9beta,10alpha,11alpha,14beta)-8,11,14-trihydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside A
(2beta,3Z,7alpha,8E)-3,8-Dolabelladiene-2,7,16,18-tetrol|chrozophorozide B
12beta,16alpha,17,19-tetrahydroxy-ent-kaurane 19-O-beta-D-glucopyranoside
Mupirocin
An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].
Glucoraphanin (4-methylsulfinylbutyl glucosinolate)
4-Methoxyglucobrassicin (4-Methoxy-3-indolylmethyl glucosinolate)
Neoglucobrassicin (1-Methoxy-3-indolylmethyl glucosinolate)
lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid
9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid
2-({4-hydroxy-1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
1-(5-hydroxy-3-methylpentyl)-5,5,8a-trimethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid
2-{[14,15-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(4r,4ar,4br,5r,7s,8r,8ar,10ar)-7-ethenyl-5,8,8a-trihydroxy-1,1,4a,7-tetramethyl-decahydrophenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3,13-clerodadiene-6,15,16,19-tetrol; (ent-6β,13z)-form,19-o-beta-d-glucopyranoside
{"Ingredient_id": "HBIN006924","Ingredient_name": "3,13-clerodadiene-6,15,16,19-tetrol; (ent-6\u03b2,13z)-form,19-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H44O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8455","PubChem_id": "NA","DrugBank_id": "NA"}
